Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

VIGL

Vigil Neuroscience (VIGL)

Vigil Neuroscience Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VIGL
DateTimeSourceHeadlineSymbolCompany
09/01/202508:05GlobeNewswire Inc.Vigil Neuroscience Highlights 2024 Corporate Achievements and Upcoming 2025 MilestonesNASDAQ:VIGLVigil Neuroscience Inc
20/12/202410:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIGLVigil Neuroscience Inc
15/11/202402:00Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:VIGLVigil Neuroscience Inc
12/11/202423:00GlobeNewswire Inc.Vigil Neuroscience to Present at Upcoming Investor ConferencesNASDAQ:VIGLVigil Neuroscience Inc
07/11/202423:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VIGLVigil Neuroscience Inc
07/11/202423:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIGLVigil Neuroscience Inc
07/11/202423:00GlobeNewswire Inc.Vigil Neuroscience Reports Third Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:VIGLVigil Neuroscience Inc
05/11/202423:00GlobeNewswire Inc.Vigil Neuroscience to Present at Guggenheim Healthcare Innovation ConferenceNASDAQ:VIGLVigil Neuroscience Inc
10/10/202409:22Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:VIGLVigil Neuroscience Inc
20/09/202407:20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VIGLVigil Neuroscience Inc
17/09/202421:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIGLVigil Neuroscience Inc
17/09/202421:00GlobeNewswire Inc.Vigil Neuroscience Announces FDA Has Removed Partial Clinical Hold on VG-3927NASDAQ:VIGLVigil Neuroscience Inc
17/09/202406:05GlobeNewswire Inc.Vigil Neuroscience to Present at Cantor Global Healthcare ConferenceNASDAQ:VIGLVigil Neuroscience Inc
29/08/202421:00GlobeNewswire Inc.Vigil Neuroscience to Present at Upcoming September Investor ConferencesNASDAQ:VIGLVigil Neuroscience Inc
13/08/202421:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VIGLVigil Neuroscience Inc
13/08/202421:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIGLVigil Neuroscience Inc
13/08/202421:00GlobeNewswire Inc.Vigil Neuroscience Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:VIGLVigil Neuroscience Inc
13/08/202407:02Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:VIGLVigil Neuroscience Inc
02/08/202406:05GlobeNewswire Inc.Vigil Neuroscience Highlights Publication on ALSP Genetic Mutation Prevalence in Neurology GeneticsNASDAQ:VIGLVigil Neuroscience Inc
31/07/202406:05GlobeNewswire Inc.Vigil Presents Data on its Small Molecule TREM2 Agonist Program at 2024 Alzheimer's Association International Conference (AAIC)  NASDAQ:VIGLVigil Neuroscience Inc
24/07/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIGLVigil Neuroscience Inc
24/07/202421:00GlobeNewswire Inc.Vigil Neuroscience Announces Interim Data from its Ongoing Phase 1 Clinical Trial Evaluating VG-3927 in Healthy Volunteers Supporting Continued Development in Alzheimer’s DiseaseNASDAQ:VIGLVigil Neuroscience Inc
19/07/202406:05GlobeNewswire Inc.Vigil Announces Upcoming Presentations on its Small Molecule TREM2 Agonist VG-3927 at the 2024 Alzheimer's Association International ConferenceNASDAQ:VIGLVigil Neuroscience Inc
18/07/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIGLVigil Neuroscience Inc
18/07/202421:00GlobeNewswire Inc.Vigil Neuroscience Provides Update on Clinical Development Strategy to Pursue Potential Accelerated Approval Pathway for Iluzanebart in ALSPNASDAQ:VIGLVigil Neuroscience Inc
27/06/202416:00GlobeNewswire Inc.Vigil Neuroscience Announces $40 Million Strategic Investment from SanofiNASDAQ:VIGLVigil Neuroscience Inc
08/06/202407:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIGLVigil Neuroscience Inc
08/06/202407:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIGLVigil Neuroscience Inc
07/06/202406:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIGLVigil Neuroscience Inc
30/05/202421:05GlobeNewswire Inc.Vigil Neuroscience to Present in Upcoming June Investor ConferencesNASDAQ:VIGLVigil Neuroscience Inc
 Showing the most relevant articles for your search:NASDAQ:VIGL